Diagmmr®

FROM SAMPLE TO DIAGNOSIS

DiagMMR® is designed to be a predictive diagnostic tool that enables preventive follow-up and counselling for affected mutation carriers who are at high risk for developing Lynch syndrome related cancers.

While current LS diagnosis relies on tumor studies, the quantitative DiagMMR® method allows carrier diagnosis based on a non-invasive tissue sample before the person has developed a cancer, without the knowledge and details of an inherited mutation.

DiagMMR Laboratory

DIAGNOSTIC BENEFITS

DiagMMR® innovation has several outstanding benefits compared to the current diagnostic tools: